COVID Vaccine Distribution Plan From National Academies Leaves Room For Adjustments Based On Trial Results
Draft allocation framework expects health care workers would take up much of the initial vaccine supply and suggests the elderly and people with two comorbid conditions receive vaccination next. NAM suggests states get a population-based allotment, leaving local officials to make many of the tough decisions under the framework, which could be adjusted based on clinical trial data.
You may also be interested in...
US FDA officials fear comparator arms would be unwieldy for ongoing trials as they consider alternative methods to measure efficacy if placebo controls can't be maintained for the studies of other candidate vaccines once a product is on the market.
Former FDA Commissioner says agency could grant an EUA for a vaccine, but require it meet the standard for full approval, and then roll it out gradually with postmarket data collection.
National Academy of Medicines draft on equitable COVID-19 vaccine allocation needs more overt strategies to address equity, commenters say. Meanwhile, competing national and state efforts to address COVID-19 vaccination allocation could lead to confusion as the country struggles to fairly divide limited resources among many high-risk populations.